What conditions have the most trials recruiting in Arzo, Switzerland?

In Arzo, Switzerland, the conditions with the most recruiting trials are NASH (3), Liver Fibrosis (1), Metabolic Dysfunction Associated Steatohepatitis (1).

Clinical trials recruiting in Arzo, Switzerland

Recruiting trials

Conditions

Phase breakdown

Phase 1 1Phase 3 2

Conditions recruiting in Arzo, Switzerland

Condition	Trials
NASH	3
Liver Fibrosis	1
Metabolic Dysfunction Associated Steatohepatitis	1
Metabolic Dysfunction Associated Steatohepatitis (MASH)	1

Recruiting trials in Arzo, Switzerland

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
NCT06632457 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
NCT06632444 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BAR502 in Healthy Subjects
NCT06705998 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Arzo, Switzerland?

3 recruiting trials have at least one study site in Arzo, Switzerland.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.